Search Results - "CETANI, F"

Update on parathyroid carcinoma by Cetani, F., Pardi, E., Marcocci, C.

“…Introduction Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing severe primary hyperparathyroidism (PHPT). PC is mainly a sporadic…”
Get full text

Familial states of primary hyperparathyroidism: an update by Cetani, F., Dinoi, E., Pierotti, L., Pardi, E.

“…Background Familial primary hyperparathyroidism (PHPT) includes syndromic and non-syndromic disorders. The former are characterized by the occurrence of PHPT…”
Get full text

Macro-PTH, a rare cause of unexplained elevated serum PTH levels by Cetani, F., Centoni, R., Marcocci, C.

Get full text

Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism by Meola, A., Vignali, E., Matrone, A., Cetani, F., Marcocci, C.

“…Purpose To evaluate adherence to European Society of Endocrinology guidelines and risk of renal complications in patients with chronic post-operative…”
Get full text

When to suspect infantile hypercalcemia-1? by Brancatella, A., Cappellani, D., Pierotti, L., Dinoi, E., Sardella, C., Borsari, S., Piaggi, P., Baldinotti, F., Caligo, M A., Marcocci, C., Cetani, F.

“…Purpose The screening test to suspect infantile hypercalcemia-1 (HCINF1) is the measure of 25(OH)D 3 /24,25(OH) 2 D 3 ratio at mass spectroscopy (MS). When the…”
Get full text

Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism by Saponaro, F., Alfi, G., Cetani, F., Matrone, A., Mazoni, L., Apicella, M., Pardi, E., Borsari, S., Laurino, M., Lai, E., Gemignani, A., Marcocci, C.

“…Purpose Hypoparathyroidism (HypoPT) is a rare endocrine disease and conventional therapy is based on calcium and vitamin D analogues. Conventional therapy does…”
Get full text

Renal complications and quality of life in postsurgical hypoparathyroidism: a case–control study by Mazoni, L., Matrone, A., Apicella, M., Saponaro, F., Borsari, S., Pardi, E., Cosci, B., Biagioni, I., Rossi, P., Pacciardi, F., Scionti, A., Elisei, R., Marcocci, C., Cetani, F.

“…Purpose Conventional therapy (calcium and activated vitamin D) does not restore calcium homeostasis in patients with chronic hypoparathyroidism (HypoPT) and is…”
Get full text

Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2 by Romei, C., Pardi, E., Cetani, F., Elisei, R.

“…Multiple endocrine neoplasia (MEN) are clinical inherited syndromes affecting different endocrine glands. Three different patterns of MEN syndromes can occur…”
Get full text

Clinical and molecular characteristics of two Italian kindreds with hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome by Dinoi, E., Pierotti, L., Mazoni, L., Citro, F., Della Valentina, S., Sardella, C., Borsari, S., Michelucci, A., Caligo, M. A., Marcocci, C., Cetani, F.

“…Purpose Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome, also known as Barakat syndrome, is a rare autosomal dominant disease characterized by…”
Get full text

Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up by Ferrari, F., Marcocci, C., Cetani, F.

Get full text

Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene by Borsari, S., Marcocci, C., Cetani, F.

Get full text

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism? by Saponaro, F., Cetani, F., Mazoni, L., Apicella, M., Di Giulio, M., Carlucci, F., Scalese, M., Pardi, E., Borsari, S., Bilezikian, J. P., Marcocci, C.

“…Context The latest guidelines of the 4th International Workshop on Asymptomatic Primary Hyperparathyroidism (aPHPT) reintroduced hypercalciuria (i.e. urinary…”
Get full text

Update on the use of cinacalcet in the management of primary hyperparathyroidism by Marcocci, C., Cetani, F.

“…Cinacalcet is an allosteric modulator of the calcium sensing receptor acting to sensitize this receptor to the extracellular calcium. Cinacalcet has been shown…”
Get full text

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment by Marcucci, G., Beccuti, G., Carosi, G., Cetani, F., Cianferotti, L., Colao, A. M., Di Somma, C., Duradoni, M., Elefante, A., Ghizzoni, L., Giusti, M., Lania, A. G., Lavezzi, E., Madeo, B., Mantovani, G., Marcocci, C., Masi, L., Parri, S., Pigliaru, F., Santonati, A., Spada, A., Vera, L., Brandi, M. L.

“…Purpose The main purpose of this study was to investigate the effects of 12 months of rhPTH (1–84) (Natpar ® ) treatment in a cohort of patients selected…”
Get full text

Whole exome sequencing in familial isolated primary hyperparathyroidism by Cetani, F., Pardi, E., Aretini, P., Saponaro, F., Borsari, S., Mazoni, L., Apicella, M., Civita, P., La Ferla, M., Caligo, M. A., Lessi, F., Mazzanti, C. M., Torregossa, L., Oppo, A., Marcocci, C.

“…Purpose Familial isolated hyperparathyroidism (FIHP) is a rare inherited disease accounting for 1% of all cases of primary hyperparathyroidism (PHPT). It is…”
Get full text

Clinical presentation and management of patients with primary hyperparathyroidism in Italy by Saponaro, F., Cetani, F., Repaci, A., Pagotto, U., Cipriani, C., Pepe, J., Minisola, S., Cipri, C., Vescini, F., Scillitani, A., Salcuni, A., Palmieri, S., Eller-Vainicher, C., Chiodini, I., Madeo, B., Kara, E., Castellano, E., Borretta, G., Gianotti, L., Romanelli, F., Camozzi, V., Faggiano, A., Corbetta, S., Cianferotti, L., Brandi, M. L., De Feo, M. L., Palermo, A., Vezzoli, G., Maino, F., Scalese, M., Marcocci, C.

“…Purpose Evaluation of the phenotype of primary hyperparathyroidism (PHPT), adherence to International Guidelines for parathyroidectomy (PTx), and rate of…”
Get full text

A large functioning parathyroid lipoadenoma by Cetani, F., Torregrossa, L., Marcocci, C.

Get full text

Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism by Cetani, F., Pardi, E., Aretini, P., Saponaro, F., Borsari, S., Mazoni, L., Apicella, M., Civita, P., La Ferla, M., Caligo, M. A., Lessi, F., Mazzanti, C. M., Torregrossa, L., Oppo, A., Marcocci, C.

“…Unfortunately, the 13th author name has been published incorrectly in the original publication…”
Get full text

Molecular pathogenesis of primary hyperparathyroidism by Cetani, F, Pardi, E, Borsari, S, Marcocci, C

“…Primary hyperparathyroidism (PHPT) is a common endocrinopathy, mostly caused by a monoclonal parathyroid adenoma. The hereditary syndromes include multiple…”
Get full text

Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling by Cetani, F., Saponaro, F., Banti, C., Cianferotti, L., Vignali, E., Chiavistelli, S., Viccica, G., Pinchera, A., Marcocci, C.

“…Background: Patients with primary hyperparathyroidism (PHPT) with contraindications to parathyroidectomy (PTx) or persistent PHPT have few non surgical…”
Get full text